The Federal Trade Commission (FTC) has put more than 1,100 businesses, including many direct sales companies, on notice that if they deceive or mislead consumers about potential earnings, the agency may use its authority to target them with large civil penalties.

Momentum Factor CEO Jonathan Gilliam thoroughly discusses the importance of automated digital compliance for direct selling companies in this original white paper.

By popular demand, the Direct Selling Legal & Compliance Summit is returning February 16-18, 2022, to the W Austin Hotel! We are so excited to host everyone for this important event and can't wait to meet up in Austin. Tickets and rooms for the event - headlined by keynote speaker Andy Fastow - are now available!

Momentum Factor CEO Jonathan Gilliam was recently featured in the Verb Technology Direct Sales Masterclass Series to discuss compliance in direct sales and the current regulatory climate facing the industry.

The Direct Selling Association will be holding its next Direct Selling Compliance Certification Program beginning on Oct. 13 and the Momentum Factor team will again be leading the compliance module.

If you missed the Future of Compliance in Direct Selling webinar on Sept. 8 between DirectScale CEO Rodger Smith and Momentum Factor CEO Jonathan Gilliam, don't worry - a recording of this important conversation is now available.

By successfully utilizing Section 19 of the FTC Act, the Federal Trade Commission has found a new avenue to restitution after Section 13(b) was vacated by the Fifth Circuit. An article from JD Supra details this important development.

As social media has become more and more a part of our daily lives, direct sellers have applied their relationship-building skills to these channels in order to expand their customer connections and pivot towards a new e-commerce strategy: social selling.

Regulatory action is on the rise as the U.S. Food and Drug Administration and the Federal Trade Commission are coordinating consumer protection efforts.

The FDA and the FTC posted warning letters to 10 companies for illegally selling dietary supplements that claim to cure, treat, mitigate, or prevent diabetes, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).